Healthy volunteers help test new Drug's safety
NCT ID NCT06070857
First seen Nov 20, 2025 · Last updated May 20, 2026 · Updated 23 times
Summary
This study tested the safety and how the body handles a new drug called LV232 in 81 healthy Chinese adults. Participants received either the drug or a placebo, and researchers monitored side effects and drug levels in the blood. The goal was to gather early safety data, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY SUBJECTS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Shanghai Xuhui Central Hospital
Shanghai, Shanghai Municipality, 201900, China
Conditions
Explore the condition pages connected to this study.